CRA International enters its May 7 Q1 earnings call with an interesting split in positioning: short sellers have been steadily reducing exposure while options traders have swung notably bearish over the past two weeks.
The options story is the cleaner signal heading into the print. The put/call ratio is running well above its recent average at 2.13, roughly one standard deviation above the 20-day mean of 1.90. That reading is close to the highest level of the past year — the 52-week peak was 2.23 — and has held elevated since late April. Options open interest is thin on a stock this small, but the persistent skew toward puts suggests at least some holders are paying for downside protection ahead of the release.
Short interest, meanwhile, has been moving in the opposite direction. Shorts have cut exposure meaningfully — SI as a percentage of free float has fallen from nearly 4.9% in late March to 3.9% now, a drop of roughly one full percentage point in five weeks. The single sharpest move came around April 9-10, when SI fell from the 4.8% range to 4.1% in one session. Borrowing conditions reflect the reduced urgency: cost to borrow is cheap at 0.50% APR, and availability in the lending market remains wide — the borrow market shows no meaningful squeeze pressure. ORTEX's short score of 33.2 is in the lower half of the universe, consistent with a stock where shorts are present but not especially aggressive.
The Street view is effectively one voice. Barrington Research's Kevin Steinke has carried an Outperform rating for years, most recently maintaining a $245 price target in early March. With CRAI trading around $154.55, that implies a roughly 60% return to target — a gap that likely reflects the stock's underperformance against earlier expectations rather than a sudden burst of analyst conviction. There is no recent activity from any other firm; analyst coverage here is sparse. The bull case centres on demand recovery in financial and management consulting, margin expansion, and continued capital return. Bears point to a challenging regulatory environment — stagnant scrutiny reduces the demand backdrop for CRAI's litigation and competition work — and the concentration risk from US-heavy revenues.
On institutional ownership, the shareholder base is stable. BlackRock and Fidelity each hold roughly 9% of shares, with Vanguard and Neuberger Berman close behind at around 6% each. CEO Paul Maleh holds just over 1.8% of the company and received an equity award in mid-April — a routine grant rather than a market-signal purchase. The small open-market sell transactions from the EVP and General Counsel on April 10 were token amounts — collectively under $80,000 — and carry no directional weight.
The last earnings print, in late February, produced a 7.7% one-day gain that extended to nearly 16% over the following week, so the stock has a recent history of rewarding results with a meaningful pop. Peers have had a mixed week: FCN fell 3.2% while EXPO dropped 2.0%, but CBZ and NSP surged 8.6% and 14.9% respectively — the dispersion suggests sector-level macro noise rather than a clean read-through. What to watch on May 7 is the project lead flow commentary: the key question is whether the uptick in new project originations seen in the prior quarter has held into the new fiscal year, which the SI unwind and lingering options hedging together suggest the market is not yet fully convinced on.
See the live data behind this article on ORTEX.
Open CRAI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
